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Abstract
The first TCR-dependent checkpoint in the thymus determines αβ vs. γδ T lineage fate and sets the
stage for later T cell differentiation decisions. We had previously shown that early T cells in NOD
mice that are unable to rearrange a TCR exhibit a defect in checkpoint enforcement at this stage.
To determine if T cell progenitors from wild type NOD mice also exhibit cell-autonomous defects
in development we investigated their differentiation in the Notch-ligand presenting OP9-DL1 co-
culture system, as well as by analysis of T cell development in vivo. Cultured CD4 and CD8
double negative (DN) cells from NOD mice exhibited major defects in the generation of CD4 and
CD8 double positive (DP) αβT cells, while γδT cell development from bipotent precursors was
enhanced. Limiting dilution and single cell experiments show that the divergent effects on αβ and
γδ T cell development did not spring from biased lineage choice but from increased proliferation
of γδT cells and impaired accumulation of αβT lineage DP cells. In vivo, NOD early T cell subsets
in the thymus also show characteristics indicative of defective β-selection, and peripheral αβT
cells are poorly established in mixed bone marrow chimeras, contrasting with strong γδT as well
as B cell repopulation. Thus, NOD T cell precursors reveal divergent, lineage-specific
differentiation abnormalities in vitro and in vivo from the first TCR-dependent developmental
choice point, which may have consequences for subsequent lineage decisions and effector
functions.
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Introduction
T cells in all jawed vertebrates can be divided into two major subsets, those that use αβ T
cell receptors (TCR) and those that use γδ TCR. These two major lineages are broadly
similar, both requiring successful TCR gene rearrangement to develop and utilizing many of
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the same effector genes. Yet accumulating evidence shows that their development is
promoted by different balances of transcription factors, activating signals, and inputs from
Notch-Delta interaction. While most of these effects have been seen in the artificial context
of targeted mutant mice, we here present evidence that there are unexpectedly sharp,
divergent abnormalities in αβT and γδT cell developmental programming in the
unmanipulated genetic background of the autoimmune-prone, nonobese diabetic (NOD)
mouse.
All T cell lineages arise from the few multipotent precursor cells that migrate from bone
marrow to the thymus, which provides the environmental signals, including Notch ligands
and cytokines, needed for these progenitor cells to carry out the process of T lineage
specification and commitment. These cells undergo extensive proliferation and an ordered
series of differentiation stages characterized by a progressive induction of T cell identity
genes and loss of stem cell and other genes permitting alternative fate choices (1). These
stages are defined by specific changes in cell surface markers. In mice, the early double
negative (DN) stages lack CD4 and CD8, as well as rearranged TCR, and differentiate first
from CD44+CD25−cKit+ DN1 cells (or early thymic precursors (ETPs)) to
CD44+CD25+cKit+ DN2 cells and then to CD44-CD25+cKitlo DN3 cells (2, 3). T cell
receptor (TCR) rearrangements are ongoing from the DN2 through the DN3 stage, and
differentiation past the first T cell checkpoint at DN3 requires successful rearrangement and
expression of a TCRβ chain or TCRβ and δ chains. If TCRβ molecules are expressed, they
pair with invariant preTα molecules, triggering TCR signaling that results in β-selection
(4-6). This is a process of rapid, major regulatory changes and extensive proliferation,
coupled with effects on survival, culminating in differentiation to the CD4+CD8+ double
positive (DP) stage. These DP cells undergo TCRα rearrangements and further selection and
differentiation, based primarily but not solely on properties of the new αβTCR. T cells with
strongly self-reactive TCRs are negatively selected and die, while cells with more moderate
specificity for self-antigens differentiate into a variety of effector populations including CD4
or CD8 single positive T cells, as well as unconventional cells like regulatory T cells, NKT,
and CD8αα cells, before exiting to the periphery (reviewed in (7)). Alternatively, if β and δ
TCR chains are rearranged before a TCRβ chain, γδTCR expression triggers an alternative
differentiation program, γδ-selection, that typically results in a lower level of proliferation
and no upregulation of CD4 or CD8 (reviewed in (8)). The nature of the receptor itself does
not necessarily determine whether a cell will undergo αβT or γδT cell programming, but the
intensity and timing of that signal is crucial, with preTα/TCRβ typically giving weaker and
γδTCR stronger signals (9, 10). Thus, β- and γδ-selection represent the first of several stages
at which survival and further differentiation of a cell is dependent upon characteristics of the
cell’s TCR and associated signaling apparatus. Many T cell identity genes, including those
needed for TCR signaling, are turned on in the DN2-DN3 stages for first use at β- or γδ-
selection (1). For this reason, any fundamental genetically-determined defect in T cells
affecting signaling, survival or proliferation could alter fate choices at this stage while also
having an effect on, without being complicated by, subsequent lineage choices, positive and
negative selection, and peripheral activation events.
Autoimmune Type 1 diabetes (T1D) results from abnormal responses to self antigens by
peripheral T cells, due to both a failure of T cell self-tolerance mechanisms and breakdown
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of active T cell suppression of these autoreactive cells (reviewed in (11)). A number of
studies have reported that different T lineages from autoimmune diabetes-prone NOD mice
have defective numbers and/or responses to various stimuli relative to cells from other non-
autoimmune mouse strains, as possible factors contributing to disease. The T cell lineages
implicated in T1D include CD4, CD8, NKT, and regulatory αβT cells, as well as γδT IEL
cells (11-16). However, by the time mature T cells initiate and propagate an autoimmune
response to peripheral tissues, they have already undergone a sequence of prior
developmental choices and signaling encounters with antigen presenting cells that may have
contributed cumulatively to their abnormalities. Therefore, to shed light on the possible
origins of inappropriate responses of T cells in NOD mice, we have turned to the earliest
stage when the TCR response machinery is first used to dictate cell fate. This is during
intrathymic development, at the checkpoint where commitment to the αβ and γδ T cell
lineages is established.
Although T cell populations in the thymus of NOD mice appear to be generally similar to
those of other mouse strains in steady state (17, 18), the early DN populations have not been
investigated in great detail. Several studies have reported abnormalities in NOD thymic
development. We previously reported that thymocytes from NOD.Prkdcscid/scid and NOD-
Rag1−/−mice appear to break through the β-selection checkpoint, resulting in the aberrant
development of DP cells (19). NOD thymuses have also been shown to accumulate newly
differentiated DP cells more slowly than conventional strains after dexamethasone-induced
depletion of the DP compartment (20). Furthermore, a number of studies show defects in
NOD DP cell responses to various stimuli, including responsiveness to ConA (21), apoptosis
induced by glucocorticoids and β-irradiation (20) or anti-CD3ε (22), and responses to thymic
selection signals (23-26). NOD mice also have defects in development of NKT cells from
DP (17, 27). All of these traits point to potential alterations in TCR signaling in NOD
thymic T cells, which may have consequences for mature T cell activity (12). The nature of
early T cell responses is set by the cellular signaling components, which in turn have effects
on the thresholds for distinct responses including positive and negative selection of αβTCR+
DP cells (reviewed in (7, 28)).
The earliest stages of T cell development are difficult to assess in the presence of ongoing
TCR rearrangements because they represent only a small fraction of total thymocytes and
because of the tremendous proliferation that occurs during differentiation from DN stages to
DP, which can mask underlying developmental defects. In addition, steady-state proportions
of thymic populations are affected by lineage decisions, cell death, and emigration (7). We
have therefore used several approaches to compare the earliest stages of T cell development
and lineage decisions in NOD to non-autoimmune C57BL/6 (B6) mice. To investigate the
intrinsic developmental potential of NOD T cell precursors, we took advantage of the
Notch-ligand expressing OP9-delta-like 1 (DL1) co-culture system, which has been used
extensively to elucidate the roles of Notch and other factors on the T cell developmental
process in mice and humans (29-32). We also carried out detailed flow cytometric analyses
of early T cell developmental stages as well as tracking population dynamics by BrdU
labeling in vivo and in mixed bone marrow chimeras. Our findings demonstrate that NOD
early T cells exhibit impaired β-selection, while γδ-selection is strongly enhanced.
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Materials and Methods
Mice
NOD/ShiLtJ, C57BL/6J, BALB/cJ, NOD.Rag1−/− and B6.Rag1−/− mice were obtained
from Jackson Laboratories (Bar Harbor, ME) and then bred and maintained in micro-isolator
cages in our specific pathogen-free mouse colony in the Caltech Animal Resources facility.
(NOD X B6)F1.Rag1−/− mice used for bone marrow chimeras were bred in our facility from
the parent strains. Mice were used for these studies at 4-7 weeks of age. Euthanasia and
animal care followed NIH guidelines, under protocols approved by the Institute Animal Care
and Use Committee.
Antibody staining, cell sorting, and flow cytometric analysis
To isolate DN populations, mice were sacrificed, their thymuses were removed and single
cell suspensions made. Mature cells were depleted as previously described (33) by staining
with biotinylated antibodies to CD8a, TCRγδ, TCRβ, Gr1, Ter119, CD122, NK1.1, Dx5,
and CD11c, after which the cells were incubated with streptavidin coated magnetic beads
and then passed through a magnetic column (Miltenyi Biotec, Auburn, CA). Eluted DN cells
were either stained for direct flow cytometric analysis or for the sorting of specific DN
populations into OP9 cultures. ETP (CD25−CD44hi c-Kithi), DN2 (CD25+CD44hic-Kithi),
DN3a (CD25+CD44lo c-Kitlo CD27loFSClo), and DN3b (CD25+CD44lo c-Kitlo
CD27hiFSChi) precursor cells, as well as γδT cells, were sorted from DN cells using a
FACSAria with Diva software (Becton Dickinson Immunocytometry Systems (BDIS),
Mountain View, CA). For analysis of co-cultures, cells were forcefully pipetted, filtered
through nylon mesh to remove stromal cell clumps, and stained for CD45, to identify input
cells, plus various combinations of lineage identifying antibodies. Cells were analyzed using
a FACSCalibur (BDIS) or MACSQuant (Miltenyi) and FlowJo software (Treestar, Ashland,
OR). Antibodies were purchased from eBiosciences (San Diego, CA). For intracellular
staining, DN thymocytes were stained with surface markers, fixed and permeabilized using
Cytofix/Cytoperm Kit (BD) and stained with conjugated antibodies to TCRβ or TCRγδ.
Cell culture
OP9-DL1 co-cultures were carried out as previously described (33, 34). For T cell
development, thymic DN cells were placed on monolayers of OP9-DL1, supplemented with
2.5 ng/ml IL-7 and 5 ng/ml Flt3L. After 7 days cultures were transferred to new plates with
fresh OP9-DL1 cells and the medium replaced, supplemented with 1 ng/ml IL-7. Human
forms of the cytokines were used and obtained from Peprotech (Rocky Hill, NJ). Tissue
culture media and fetal calf serum were obtained from Invitrogen/Gibco (Carlsbad, CA). For
bone marrow cultures, cells were column-depleted of mature cells using biotinylated
antibodies to CD3e, CD4, CD8, CD19, Gr-1, Ter119, CD11b, NK1.1 as described above.
105 cells were plated on OP9-DL1 monolayers in 10 cm tissue culture flasks (Corning) with
the addition of 10 ng/ml IL-7 and 5 ng/ml Flt3L. After 6 days, the bone marrow-derived
cells, which are predominantly DN1 and DN2 cells, were removed from the monolayers and
replated on OP9-DL4 cells with 2 ng/ml IL-7. For proliferation assays, DN cell subsets were
FACS sorted and then stained for 8 min at 37oC with 5 μM CFSE (Cell Trace CFSE
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Proliferation Kit, Invitrogen), in accordance with the manufacturer’s instructions, before
they were placed in culture.
In vivo assays
For BrdU pulse-labeling of thymocytes, B6 and NOD mice were injected intraperitoneally
with 1 mg Bromo-deoxyuridine (BrdU) in 0.2 ml PBS twice four hours apart. Mice were
sacrificed after 1, 2 and 3 days and their thymocytes were stained with surface antibodies
followed by intracellular staining for BrdU-FITC in accordance with BrdU Flow Kit
instructions (BD Biosciences). For mixed bone marrow chimeras, female 8-16 week old
NOD X B6)F1.Rag1−/− mice were irradiated with 400 Rads using a Cs-137 source irradiator
and retroorbitally injected with 5 × 106 bone marrow cells each from NOD and B6 mice,
mixed 1:1, and assayed between 5 and 9 weeks after cell injection. To reduce the risk of
infection, mice were housed using autoclaved cages, bedding and food, and were treated
with an antibiotic, Baytril (Bayer), in drinking water for several days before and two weeks
after irradiation.
RNA extraction and quantitative RT-PCR analysis
RNA was isolated from sorted TCRγδ+ cells from B6 and NOD mouse thymuses and real
time quantitative (Q)PCR carried out as previously described (19). Briefly, cells were lysed
in Qiazol (Qiagen, Valencia, CA), RNA isolated using RNAeasy extraction kits (Qiagen),
and cDNA reverse transcribed using random hexamers and SuperscriptIII (Invitrogen)
following the manufacturer’s instructions. cDNA samples were diluted and mixed with
gene-specific primers and SyBr GreenER (Invitrogen) and run on an ABI Prism 7900HT
Sequence Detector (ABI, Mountain View, CA). Primers used for this study were synthesized
by Eurofins MWG Operon (Huntsville, AL) and have been published previously (19, 35, 36)
except for those for Sox13: Forward- GAGAAGCTGCTGTCCAGTGAC and Reverse-
GACCAAAAGCTGGAGTTCCTT. Vβ1.1 and Jβ4 primer sequences were obtained from
Verykokakos et al. (37). Results were calculated using the ΔCt method, normalizing all
samples to Actb expression.
Results
NOD DN cells are impaired in the generation and maintenance of αβT lineage DP cells, but
not γδT cells, in OP9-DL1 co-cultures
Because steady state thymic T cell populations reflect a combination of intrinsic and
extrinsic factors, proliferation, cell death, and emigration, which can mask developmental
differences, we wished to assess the intrinsic developmental potential of T cell precursors
from B6, NOD, and BALB/c mice under the same environmental conditions using the OP9-
DL1 co-culture system (30, 34). Immature DN thymocytes were purified by depletion of
mature cells and placed in OP9-DL1 co-culture with IL-7 and Flt3L. When analyzed on day
12 of culture, B6 and BALB/c DN cells were found to generate and maintain high
percentages of DP cells as expected, while NOD DN cells produced a much lower
proportion of DP cells under the same conditions (Fig. 1A, top panels). In the same cultures,
NOD DN cells produced a higher proportion of γδT cells relative to B6 and BALB/c DN
cells (Fig. 1A, bottom panels).
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To assess the kinetics of stage-specific αβ vs. γδ lineage development of NOD and B6 DN
cells, we tracked the development of purified intrathymic DN precursor subsets, including
DN1/ETP (cKithiCD25−CD44hi), DN2 (cKithiCD25+CD44hi), and DN3a
(cKitloCD25+CD44loCD27loFSClo) populations that retain both γδ and αβ T cell potential,
as well as DN3b cells (cKitloCD25+CD44loCD27hiFSChi), which, as we previously showed
for B6 mice, have already completed TCRβ rearrangement and pre-TCR signaling (34).
Although NOD thymocytes also upregulate CD27 at β-selection, they do so to a lesser extent
than B6 cells (see below), so NOD and B6 DN3b cells were enriched by sorting based upon
combined expression of relatively high levels of CD27 and large size (high forward scatter
(FSC), while DN3a cells were sorted based upon lower CD27 and lower FSC (38).
When precursor DN subsets from NOD and B6 thymuses were placed in OP9-DL1 co-
cultures, neither B6 nor NOD DN1/ETP and DN2 cells generated DP cells by day 7 (Fig.
1B). However, by day 14, B6 DN1/ETP and DN2 cell cultures contained abundant cells that
had differentiated to the DP stage while, in contrast, NOD DN1 and DN2 cells produced few
if any DP cells. This is not due simply to a delay in differentiation, as NOD DP cell
production did not increase with time (data not shown).
In contrast, DN3 cultures from both B6 and NOD thymuses began to express CD4 and/or
CD8 by day 7 of OP9-DL1 co-culture (Fig. 1B), a time point when few DN1 or DN2 cells
from either strain had turned on CD4 or CD8. Confirming the αβT cell lineage choice of the
accumulated DP cells, all cultures that contained abundant DP cells, including B6 and NOD
DN3a and DN3b at day 7, as well as all B6 DN subsets at day 14, clearly expressed surface
TCRβ, while those NOD and B6 cultures with few DP cells express very little TCRβ (Fig.
1C). At day 7, the percentage of DP from NOD DN3a cells was moderately lower in
comparison with B6 DN3a cells, while NOD DN3b cells appeared to produce fewer cells
overall and a lower proportion of DP cells. By day 14 the differences were even more
pronounced, with a very low proportion of DP cells in NOD DN3a cultures and very few
surviving cells in the DN3b cultures. This latter result was confirmed in further experiments
when the ability of individual post-β-selection DN3b cells to generate DP cells was tested.
Single DN3b cells were sorted from NOD and B6 thymuses and placed in OP9-DL1 co-
culture for 7 days. While all individual NOD and B6 DN3b cells proliferated and
differentiated, fewer DP cells were generated in the NOD cultures (35.2 + 8.9, mean +
SEM) as compared with B6 cultures (179.5 + 53.5) (p < 0.005, Mann-Whitney U Test).
These results suggest a possible loss of differentiation potential, proliferation, and/or
viability in the generation of DP cells from DN cells sorted both before and after β-selection
in the NOD thymus.
To identify the stages at which the initial differentiation of the NOD DN cells might be
blocked, the same cultures were stained with CD44 and CD25 at day 7 (Fig. 1D). Most of
the cells from cultures seeded with DN3a and DN3b cells from either B6 or NOD mice had
progressed to DN4, or later stages, as shown by the downregulation of CD25 and CD44 by
day 7, in agreement with their predominantly DP phenotype. While both B6 and the NOD
DN1 and DN2 cells differentiated successfully to the DN3 stage, the NOD DN1 and DN2
cell cultures produced a much lower proportion of DN4 and later cells (Fig. 1D), suggestive
of a partial block at the β-selection checkpoint from NOD DN1 and DN2 cells.
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In marked contrast to their poor production of DP cells, the DN1, DN2 and DN3a cultures
from NOD thymocytes generated γδT cells very successfully (Fig. 1E). All of the NOD
populations produced a higher proportion of γδT progeny than the corresponding B6
precursors, with DN2 cells producing the greatest differences: 2.8% from B6 and 21% from
NOD DN2 cultures on day 14. As expected, very few γδT cells were generated from sorted
DN3b cells from either strain, in agreement with our previously published results for B6
mice (34). Thus, even though NOD DN1 and DN2 cells are extremely poor at passing
through the β-selection checkpoint to generate DP αβT lineage cells in vitro, they are normal
or enhanced in their ability to produce γδT lineage cells.
These results show that NOD precursors exhibit a lineage specific intrinsic defect in
development when placed in OP9-DL1 cultures. DN3 cells from NOD mice, even those that
had undergone β-selection in the thymus, generate fewer DP cells than B6 DN3 cells, and
the earliest DN1 and DN2 T cell precursors sorted from NOD thymuses are profoundly
defective in their ability to go through β-selection in vitro. However, these cells retain the
ability to produce abundant TCRγδ+ cells.
Prior thymic contact is not required for skewing of αβ versus γδ T cell fate from NOD cells
Although the highly skewed production of αβ vs. γδ lineage cells from NOD DN cells
appears intrinsic to these thymic-derived cells, two concerns could be raised. First, these
cells might have already encountered biasing interactions in the thymus from which we
isolated them. Second, the OP9-DL1 cultures present the Delta-like 1 (DL1) Notch ligand,
whereas the Notch ligand expressed in the normal thymus is DL4, which provides a
somewhat different Notch signal to these cells (39-41). Therefore, we also tested the T-
lineage development of prethymically derived bone marrow cell progenitors in vitro,
providing Delta-like 4 (DL4) as the source of Notch ligands rather than DL1. As shown in
Figure 2A, cells derived from precursor-enriched B6 and NOD bone marrow cells (BMCs)
generate both DP and γδT cells on OP9-DL4 after 19-22 days of culture. However, NOD
progenitor cells again exhibited a poor differentiation of DP cells (left panels) and
enhancement of γδT cell generation (right panels) in comparison with those from B6 mice.
Furthermore, when NOD and B6 cells were co-cultured, similar differences in αβT vs. γδT
development were observed between the two strains (Figure 2B). As shown in two
independent cultures, NOD cells (CD45.1+) produced a lower proportion of DP cells and
more γδT cells than cultured cells from B6 mice (CD45.2+). These results confirm the
profound intrinsic and lineage-specific differences in T cell developmental programming
between NOD and B6 precursor cells.
NOD DN2 cells generate a higher absolute number of γδT cells and fewer DP cells than B6
DN2 cells in vitro
Skewed production of γδT cells relative to DP cells could result from lineage-specific
alterations in proliferation or survival as well as lineage choice itself. To distinguish
between these possibilities, we focused on the DN2 cells, which particularly differed
between NOD and B6 in terms of their abilities to generate DP vs. γδT cells in OP9-DL1 co-
cultures. First, we assessed the total cell numbers of DP and γδT cells generated from
limited numbers of precursor cells in these cultures. Ten DN2 cells from B6 and NOD
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thymuses were sorted directly into each of 24 individual OP9-DL1 cultures and analyzed by
flow cytometry on day 13. The percentage of γδT cells out of the total number of
differentiated cells [calculated as 100 ×#γδT/(#γδT plus #DP)] for each well is shown (Fig.
3A, left panel) and a highly significant difference was found between cultured B6 and NOD
DN2 cells. Although DN2 cells from NOD and B6 thymuses yielded comparable total
numbers of CD45+ cells per well, NOD cells produced significantly higher absolute
numbers of γδT cells, as well as significantly fewer DP cells (Fig. 3A, right panels). Thus,
both poor DP cell differentiation and enhanced γδT cell development contribute to the NOD
phenotype.
To determine whether or not the differences in αβT vs. γδT differentiation are the result of
alterations in lineage choice, single cell differentiation analyses were performed. Because
commitment to the γδT cell lineage may occur as early as the DN2 stage (42), we sought to
determine if DN2 cells from either mouse strain start with a biased frequency of cells
precommitted to either lineage. For this experiment single cells from two subsets of the DN2
CD44+CD25+cKithi population were tested separately based on their surface c-Kit levels,
the less mature DN2a (CD44+CD25+cKit++) cells and the more mature, T lineage
committed DN2b (CD44+CD25+cKit+) cells (33). Each well was scored for the presence
and numbers of γδT and DP cells after 13 days of OP9-DL1 culture. Results in Fig. 3B (left
panel) show again that NOD DN2 cells, both DN2a and DN2b, generally produce
proportionately more γδT cells and fewer DP cells as a percentage of total differentiated
cells than corresponding cells from B6 mice. However, differences between B6 and NOD
were clearly not due to premature commitment in cells from either strain as they exhibited
similar percentages of bipotent cells (black bars) at each stage (Fig. 3B, right panel). Almost
all DN2a cells from both strains produced both γδT and DP cells. Although the majority of
DN2b cells were still bipotent, individual DN2b cells from both NOD and B6 mice were
more likely than DN2a stage cells to generate only DP cells, a trend which continued to the
DN3a stage when few cells remained bipotent and most generated only DP cells, as shown
previously for B6 mice (34). Few single cells from either strain produced only γδT cells.
Thus, the high proportion of γδT cells and low proportion of DP cells in NOD cultures is not
a result of increased previous γδT lineage commitment of the precursors but rather the result
of enhanced γδT cell production and reduced DP cell generation after the lineage choice is
made.
NOD γδT cells proliferate more rapidly than B6 γδ T cells in vitro
The normal preponderance of αβ-lineage DP cells over γδT cells in the thymus depends not
only on the frequency of different selection events, but also on the greater extent of net
proliferation that is normally associated with the αβ-lineage program after β-selection. To
address the question of whether or not some of the differences in αβT vs. γδT cell
development are attributable to a NOD defect in proliferation, unsorted thymocytes (“All”)
as well as sorted DN1/ETP, DN2, DN3a, and DN3b populations were stained with CFSE
and placed in OP9-DL1 culture. NOD DN subsets showed similar, or slightly faster,
proliferation rates than B6 cells over the first four days of culture (Fig. 4A), ruling out a
generalized proliferation defect. Most prominently, the γδTCR-positive cells generated in
the first 4 days from NOD DN3a cultures undergo more rapid and extensive proliferation
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than γδTCR-positive cells from B6 cell cultures, while the γδTCR-negative cells from NOD
and B6 cells proliferated more similarly (Fig. 4B). Thus, the high numbers of γδT cells
generated from NOD DN cells result, at least in part, from their greater proliferation after
surface TCRγδ expression in comparison with B6 γδT cells. Furthermore, the lower
numbers of DP cells generated from NOD DN3 cells is not due to an initial defect in
proliferation after β-selection.
NOD and B6 thymic γδT cells exhibit similar patterns of gene expression
We recently reported the expression of many key T cell genes in DN populations and γδT
cells from NOD and B6 mice, and found no major differences in expression of Ptcra,
Notch1, Hes1, Tcf7, Runx1, and Bcl11b among others (33). However, recent evidence
suggests that γδT cells may be comprised of multiple lineages, distinguished by their
different dependence on specific transcription factors: Sox13, Id3 or Zbtb16/Plzf (37, 43-45).
To determine whether NOD thymocytes preferentially generate all classes of γδT cells or
just one particular subtype, cells were analyzed for expression of these transcription factor
genes as well as for diagnostic TCR-Vβ rearrangements. We sampled Vβ rearrangements
representing members of the TCR-Cβ1 cluster, which includes adult, fetal and tissue-
specific receptors (reviewed in (8)). We also assayed for Vβ1.1-Jβ4 rearrangements, which
mark a recently characterized population of innate γδT cells with Vβ1.1-Vδ6.3 TCRγδ
receptors. These cells rapidly produce IL-4 and IFN-β, upregulate Zbtb16/PLZF, a critical
transcription factor in NKT differentiation (45), and are Id3 independent (37). NOD and B6
γδT cells expressed fairly similar levels of transcripts from Vβ3, Vβ5, Vβ4, and Vβ2 to Cγ1
rearrangements, as well as Vβ1.1-Jβ4 rearrangements (Fig. 5). No differences were observed
in expression of Id3 or of the CD3e, CD247 (CD3ζ, and Sox13 genes. However, Zbtb16/Plzf
expression was somewhat higher in NOD γδT cells in comparison to B6 cells. Given the
similarity in TCR Vβ usage, this could reflect a generally elevated state of activation (45).
Thus, there appear to be few if any major differences in the types of γδ T cells produced in
NOD and B6 mouse thymuses, suggesting that the differences we observe in development
and rates of proliferation might be generalized to multiple γδT cell subsets.
NOD thymocytes exhibit multiple abnormalities around the β-selection checkpoint
A number of costimulatory and other cell surface receptors, with known effects on TCR
signals, survival, and/or proliferation, are induced at β- and γδ-selection in response to TCR
signaling via the newly produced pre-TCR and γδTCR, similar to events after the activation
of peripheral T cells. The combinations and levels of these molecules can not only indicate
the nature and intensity of the TCR signals, but also can influence further response
thresholds through their modulating and enhancing roles. The degree of CD5 upregulation,
for example, has been a useful indicator of the intensity of signals driving γδ-selection vs. β-
selection (10), and once induced, CD5 can affect further development (10) and signal
thresholds for positive and negative selection (46, 47).
We have previously shown that upregulation of the costimulatory receptor, CD27, involved
in mature T cell survival and proliferation, can be used to distinguish DN3 cells that have
rearranged and transcribed an intracellular (ic) TCRβ (DN3b) from those that are still TCR-
negative in B6 mice (34). However, NOD DN3 cells express lower amounts of CD27 after
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β-selection (icTCRβ+) (Fig. 6A, top row, left panel). The costimulatory receptor CD28,
which is not expressed until after β- (or γδ-) selection (48), and CD5, are also induced to a
lower level in TCRβ+ NOD DN cells than B6 cells (top, middle panels). These observed
differences are not due to variations in the total amount of TCRβ expressed nor to cell size,
as the icTCRβ staining intensity and forward scatter (FSC) histograms are similar between
the two strains (top, right panels).
In contrast to the results for αβT cell precursors, icTCRγδ+ cells from B6 and NOD
thymuses express similar levels of surface CD27 and CD28 (Fig. 6A, bottom row, left
panels). Furthermore, NOD γδ T cells express a broader range of surface CD5 levels, both
higher and lower, and a higher total amount of TCRγδ than that expressed by B6 γδT cells,
despite comparable cell sizes as determined by FSC profile (bottom, right panels). The
higher levels of CD27 and CD5 attained by thymic γδT cells from both NOD and B6 mice
reflect the higher intensity of signals generated at γδ-selection compared with those
generated at β-selection (9, 10). Likewise, the lower induction of CD27, CD28 and CD5 in
icTCRβ+ cells from NOD as compared to B6 mice suggests that NOD cells may experience
a weaker or otherwise altered β-selection signal, while γδT cell signals are more similar
between the two strains.
Depletion of subsets post-β-selection in the normal NOD thymus
B6 and NOD thymuses exhibit few obvious differences in their proportions of major
populations in steady state (17, 18). However, because the OP9-DL1 co-culture system
revealed major intrinsic defects in NOD differentiation at the earliest TCR dependent
checkpoint, we performed a series of detailed flow cytometric analyses of freshly purified
NOD and B6 thymocytes to evaluate more closely if DN cells within the NOD thymus
exhibit any comparable abnormalities in vivo. We found that while all DN populations are
present, as measured by CD44 and CD25 profiles, the percentages and shapes of the
differentiation plots differ (Fig. 6B, left panels). Most prominently, the levels of surface
CD25 are much higher in CD25+ cells from NOD than B6 cells, as seen in the density plots,
as well as in histograms of all CD44lo cells (including DN3 to DN4 cells) (Fig. 6B, right
panel). Furthermore, NOD thymuses consistently have a lower proportion of DN4 cells
relative to DN3 cells (lower left vs. lower right quadrants). Elevated CD25 in DN3 cells and
lower proportions of DN4 cells can be indicative of a partial block in β-selection as reported
for thymuses from mice with mutations in the pre-TCR or Notch signaling pathways
(49-52).
The generally accepted route of differentiation for B6 mouse αβT cells, after β-selection and
the downregulation of CD25 leading to the DN4 stage, is the upregulation of CD8 into
immature single-positive (ISP) cells prior to the expression of surface CD4 in the DP stage
(7). A previous study reported low numbers of CD8+ ISP cells in NOD thymuses (17). To
confirm this finding and to determine the route of differentiation from DN4 to DP in NOD
thymuses, CD8 ISP cells were distinguished from mature CD8 single positive (SP) cells by
their retention of high levels of surface CD24 (heat shock antigen, HSA), which then decline
during differentiation. B6 thymocytes follow this pattern, expressing a high percentage of
total gated CD8+ cells that are HSAhi and CD2int (ISP) cells, as compared to the mature
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HSA intermediate and CD2hi single positive (SP) CD8+ cells (Fig. 6C). However, NOD
thymocytes have a much lower percentage of CD8 ISP cells that is only partially offset by a
corresponding HSAhi CD2int CD4+ ISP population. Furthermore, none of the populations
from NOD thymuses have a major subset of cells with the same level of HSA that is
expressed by the B6 ISP cells, as indicated by the red boxes (Fig. 6C, right panels),
suggesting a paucity of cells transiting through this stage of development.
The interpretation that there might be a reduced influx into the ISP compartment from
previous stages was further supported by the kinetics of proliferation and turnover of DN
and DP subsets in B6 and NOD thymuses in vivo, as determined by the fate of a cohort of
BrdU pulse-labeled cells. A previous study reported an anomalous dip in BrdU+ DP cells in
NOD mice after 2-3 days (18). We wished to confirm and extend this finding in the context
of a β-selection defect by additional DN cell analysis. Mice were injected intraperitoneally
with BrdU, sacrificed after 1, 2 or 3 days, and the thymocytes were stained for surface
receptors and intracellular BrdU. One day after BrdU injection the proportions of labeled
cells within the DN2/DN3 (CD25hi), DN4 (CD25− CD44−), and DP populations were
similar between NOD and B6 (Fig. 6D). The DN2/3 cells were expected to accumulate
BrdU+ cells due to extensive proliferation at the DN1 and DN2 stages, although most DN3
cells normally pause in proliferation before β-selection. Over 50% of the DN4 cells were
pulse-labeled at this early time point, because cells that have passed through the β-selection
checkpoint from DN3 undergo a rapid burst of proliferation while differentiating (Fig. 4A,
DN3b cells). DP cells proliferate very little, but BrdU+ cells are expected to flow into the
DP compartment and accumulate during subsequent days due to the continuing
differentiation of the rapidly proliferating DN4 and ISP cells. Accordingly, on day 2 post-
injection, the percentage of BrdU+ DN4 cells from both B6 and NOD declined precipitously
(Fig. 6D, middle panel), as expected due to turnover and differentiation from non-labeled
DN3 precursors, confirming the pulse nature of the labeling. The B6 DP compartment
showed an almost two-fold increase in the proportion of BrdU+ cells over the proportion at
day 1, again as expected due to continuing differentiation of the BrdU+ labeled DN4 cells
from the preceding days. However, the NOD DP compartment did not show a corresponding
increase in the percentage of BrdU+ cells at day 2, but rather showed a decline. The failure
of BrdU-labeled NOD cells to become DP was not due to their retention in the DN4
compartment. The rapid loss of BrdU+ cells from all phenotypic compartments suggests that
failure to accumulate ISP cells in NOD thymuses is not due to poor proliferation or rapid
modulation of surface CD4, CD8 and HSA, but instead due to a survival failure. Taken
together, our results support the notion that NOD early T cells in vitro and in vivo have a
partial block around the β-selection checkpoint, leading to a reduction in DP cell
accumulation.
Lineage-specific differences in the establishment of αβT vs. γδT cell and B cell
populations in mixed bone marrow chimeras
To determine whether preferential development of γδT cells, as well as reduced production
of αβT cells, from NOD precursors occur in vivo as well as in vitro, we used mixed bone
marrow chimeras to compare the kinetics of T cell differentiation and export between NOD
and B6 cells in the same animal. An equal number of NOD and B6 bone marrow cells were
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injected into irradiated (NOD × B6)F1.Rag1−/− mice, which were assayed for reconstitution
at 5-9 weeks of age. Five weeks post-injection both NOD (CD45.1+) and B6 (CD45.2+)
cells were found in the thymus (Fig. 7A, left panels) with relatively normal steady state
proportions of DN, DP, SP and γδT populations established at this time. However, a lower
proportion of CD45.1+ NOD cells was found in the spleen compared with CD45.2+ B6 cells
(Fig. 7A, right panels). The NOD cells were predominantly CD19+ B cells with a T:B cell
ratio of 2.2:85 as compared with the B6 T:B ratio of 35:56 (Fig. 7A, right top panels). This
T cell repopulation defect was primarily due to disproportionately fewer TCRαβ+ T cells. In
contrast, relatively normal percentages and total yields of NOD TCRγδ cells were found.
Thus, in vivo as well as in vitro, there is an NOD defect in production of αβT cells, and this
is lineage-specific.
A summary of results from all 6 mixed bone marrow chimeric mice analyzed at 5-6 and 8-9
weeks of age is shown in Figure 7B and C. In 5/6 thymuses and 6/6 spleens from chimeric
mice, NOD cells exhibited a lower ratio of TCRαβ+:TCRγδ+ cells when compared with B6
cells in the same mouse. In agreement with the steady-state phenotype of NOD mice, this
effect was kinetic, not absolute. At the later time point, by 8-9 weeks post-injection (Fig. 7B,
#4-5), the relative proportions of TCRαβ+:TCRγδ+ cells in the thymus and spleen became
more similar between NOD and B6 than that observed at 5-6 weeks (Fig. 7B, #1-3),
indicating that NOD αβT cells eventually accumulate. The defect in NOD αβT production
was again shown to be lineage specific, as relatively high numbers of B cells were produced
in these animals (Fig. 7C). Thus, NOD BMCs were much less efficient than B6 BMCs at
producing mature αβ T cells in chimeric hosts, even though they were capable of rapidly
generating γδT and B cells. These results show that the NOD genotype confers divergent
effects on αβ and γδ lineage differentiation in vivo as well as in vitro.
DISCUSSION
The first TCR dependent checkpoint is the first of many stages in which the TCR signaling
apparatus of the cell is used for survival, lineage choice and differentiation functions. The
earliest T lineage decision, which is made at this point, is the fundamental choice between
αβT and γδT cell fates, which is determined by differences in TCR signal strength and
results in initiation of very different developmental programs. Furthermore, recent evidence
suggests that different γδT cell lineages may be selected at this point depending on the
characteristics of the rearranged TCR and transduced signal at this stage (reviewed in (43)).
The OP9-DL1 co-culture system provides the Notch ligands and other factors required by
early T cells for passage through the first TCR-dependent checkpoint and differentiation into
γδT or αβT cells and it is a powerful tool allowing detailed study of the T cell
developmental program and lineage choice in both mice and humans (29-32, 53, 54). Using
this in vitro culture system we show that NOD early DN cells are very poor at generating DP
αβT cells, while the same cells under the same conditions exhibit enhanced γδT cell
differentiation and proliferation. This was true of purified DN thymocytes as well as
precursor enriched bone marrow cells and in the presence of DL4, the normal thymic Notch
ligand, rather than DL1. Because the DN thymocytes are the progenitors of all T cell
lineages, defects expressed at these earliest stages may also be present in all subsequent
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stages and may have a major impact on later thymic selection events, lineage choices, and
peripheral developmental choices and responsiveness.
While the OP9-DL1 cell culture system may exacerbate the relatively poor DP
differentiation by NOD early T cell progenitors, we have several additional lines of evidence
that indicate that β-selection may also be defective in the NOD thymus. First, the heightened
CD25 expression in NOD DN3 cells is similar to pre-TCR and Notch mutations that give a
partial block at β-selection (49-52). Second, CD5 can be used as an indicator of the intensity
of TCR signaling (10), and β-selected icTCRβ+ cells from NOD thymuses weakly
upregulate coreceptor molecules CD5, as well as CD27 and CD28, as compared to the
corresponding populations from B6 thymuses. The low proportion of CD8+ ISP cells found
in NOD thymuses has been previously reported (17), but the paucity of HSA-intermediate
cells in any corresponding population, and the poor accumulation of DP cells in BrdU-
labeling studies, suggest that this may be due to an impairment of the cells differentiating
past β-selection to the DP compartment rather than simply use of an alternate route of
differentiation. The difference does not appear to be at the level of cell proliferation after β-
selection as DN3b cells from NOD thymuses proliferate at a rate similar to B6 DN3b cells,
as measured by CFSE. CD27 is associated with proliferation and survival of cells after β-
selection, as well as survival of peripheral CD8 T cells (55, 56), and it is possible that the
low level of CD27 upregulation upon β-selection in NOD mice may contribute to the poor
accumulation of DP cells in he BrdU experiments and in OP9-DL1 culture. Overall, these
results are consistent with previous reports showing that DP cells accumulate very slowly in
NOD thymuses after depletion of the DP compartment with dexamethasone (20), and can be
interpreted as an impairment in β-selection in NOD mice.
The preferential development of γδT cells from NOD DN subsets is not simply a
concentration artifact resulting from the poor DP differentiation in these animals. There is
evidence that some γδT cell precursors can become committed precociously at the DN2
stage (42, 57), before cells reach the conventional β-selection checkpoint. That does not
appear to be the case here, as single DN2 cells sorted from NOD thymuses were
predominantly bipotent just as in B6 thymuses, despite producing relatively higher numbers
of γδT cells compared with DP cells. Thus, the skewing of NOD differentiation towards the
γδT lineage is more likely to be due to survival and proliferation than to lineage choice. The
major differences in αβT versus γδT cell development in vitro may result from alterations in
intrinsic signaling pathways in NOD early T cells with differential effects on the two
lineages. For example, stronger intrinsic IL-7 signals, lower Notch signals, weaker β-
catenin/TCF1 activity, and stronger TCR signals have all been shown to favor the
differentiation, survival, and/or proliferation of γδT cells over αβT cells (58-62). Although
lineage choice may be normal in NOD DN cells, their ability to survive, proliferate and
differentiate in the chosen lineage may differ between β- and γδ-selected T cells. Normally,
in B6 and most strains examined, the β-selection program dictates much greater proliferative
expansion than γδ-selection. Our results imply that this difference is greatly reduced or
reversed in NOD mice.
In addition to their preferential development from NOD DN cells in OP9-DL1 culture, we
found that γδT cells generated in vivo in NOD thymuses proliferate more, express a wider
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range of surface CD5, and upregulate all assayed activation-induced receptors very well.
This suggests that NOD γδT cells may be produced as a result of unusually robust or
variable signaling responses in the thymus. Thus it is possible to interpret the preferential
development of γδT cells from NOD precursors as an outcome from a stronger or altered
TCR signal, such that γδT cell differentiation, proliferation and survival is actively promoted
(9, 10, 63, 64) while DP differentiation and survival are disfavored (54). Alternatively, the
TCR signal may not be stronger in NOD cells but they may interpret any viability-
promoting signal as a γδ T cell selection signal, thereby leaving many cells that undergo the
β-selection program starved of viability support. Although further work is needed to resolve
which intrinsic mechanisms are affecting αβ vs. γδ T cell differentiation in NOD DN cells,
there is evidence that immature and mature NOD T cells may transduce abnormal TCR
signals during activation (reviewed in (12)). In addition, NOD.Prkdcscid/scid and
NOD.Rag−/− thymocytes fail to arrest at the β-selection checkpoint, undergoing
spontaneous differentiation to DP cells without restoration of thymic cellularity (19),
suggesting that NOD DN cells, even in the absence of a rearranged TCR, may undergo a
spontaneous, but only partial, TCR signal. A number of factors can cause this type of
breakthrough phenotype including enhanced TCR and Notch signals (6, 65). Interestingly,
we previously reported data showing a higher level of Notch3 and Dtx1 expression, but not
Notch1 or Hes1, in freshly isolated NOD DN3a cells in comparison with B6 DN3a cells
(33), although the significance of this difference is not yet clear.
Recent studies have demonstrated that events at β-selection or even earlier can have a major
effect on the characteristics and further lineage choices of αβTCR+ DP cells (66-68). Loss of
a subset of differentiating cells after β-selection might result in a differentially selected DP
population that, for example, transduces a stronger than average TCR signal or is more
resistant to certain types of apoptosis. If aberrant NOD β-selection events alter the signaling
characteristics of the final DP population, this could have major ramifications for negative
and positive selection of conventional CD4 and CD8 T cells. The same could be true for the
selection of γδT cells as well as “unconventional” αβT cells with self-reactive TCRs, such as
NKT, CD8αα, and regulatory T cells (69). In addition, although little is known about
possible roles of γδT cells in autoimmunity, γδT IELs may play an important role in
peripheral tolerance and have been found to be able to control diabetes progression in NOD
mice (14). γδT cells reactive to insulin peptide B:9-23 have been reported to be generated in
NOD but not B6 mice (70) which provides further evidence of their potential role in
autoimmune diabetes. The diversity of γδT lineages, their peripheral immune responses and
their roles in disease have been a subject of great interest very recently, especially in light of
the ability of particular subsets to rapidly secrete IL-17, IFN-β and IL-4 (reviewed in (43,
71)).
The results of this study show that NOD lineage T cells have fundamental and intrinsic
abnormalities from the earliest stages in their responses to activating signals, either via TCR
or other environmental triggers, even in the absence of MHC/peptide/APC interactions.
These defects may affect lineage choices and TCR repertoires via alterations in DP selection
thresholds or alter peripheral immune responses to specific stimuli, or both. Finally, whether
or not these traits found in NOD early T development directly contribute to autoimmunity,
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these studies demonstrate that different mouse strains can show major variations in β- and
γδ-selection developmental programming, which may deviate significantly from the
currently accepted pathways.
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FIGURE 1. NOD DN cells generate and maintain few DP αβT cells while retaining γδT
development in vitro
A. Flow cytometric analyses showing the development of DP and γδT cells from magnetic
bead-purified DN cells from B6, NOD and BALB/c thymocytes, after 12 days of OP9-DL1
co-culture in 5 ng/ml IL-7 and Flt3L. Similar results were obtained from cultures harvested
on day 8 and when IL-7 concentrations were dropped to 2 ng/ml for the last 5 days of
culture or were maintained at 2 ng/ml throughout the culture period (data not shown). (B E)
Development of FACs sorted DN1, DN2, DN3a, and DN3b (post-β-selection) cells from B6
and NOD thymuses cultured in 2.5 ng/ml IL-7 and 5 ng/ml Flt3L. B. Flow cytometric plots
showing CD4 and CD8 DP cell development at days 7 and 14 from each progenitor
population. C. Histograms showing levels of surface TCRβ expression in the same cultures
for B6 and NOD cell populations at days 7 and 14 of culture. No data are shown for NOD
DN3b cells on day 14 because very few cells are remaining. D. Flow cytometric plots of
CD44 vs. CD25 showing differences in initial DN differentiation in the same cultures at day
7. E. γδT cell development in the same cultures at day 14. Percentages of cells in each gate
are indicated. These results are representative of at least 3 independent experiments.
Feng et al. Page 19
J Immunol. Author manuscript; available in PMC 2014 July 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
FIGURE 2. NOD bone marrow progenitor cells also show attenuated in vitro development of DP
αβT cells and enhanced γδT cell development
Bone marrow cells enriched for progenitors were isolated from NOD and B6 mice and
cultured on OP9-DL1 and DL4 cells as described in Materials and Methods. Flow cytometry
plots show the generation of CD4/CD8 DP cells and γδT cells from B6 and NOD bone
marrow cultures analyzed after 19 and 22 days (A) and two independent cultures established
from mixing equal numbers of NOD and B6 bone marrow cells, analyzed after 20 days (B).
Results are representative of at least 3 replicate wells from 1 of 2 independent experiments
with similar results.
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FIGURE 3. NOD and B6 DN2 cells generate more γδT and fewer DP cells in ten-cell and single
cell OP9-DL1 co-cultures but retain bipotency
A. Plots showing the relative proportion of γδT cells in comparison with DP cells generated
from each individual B6 and NOD 10-cell DN2 cell culture, calculated as %γδT/(γδT + DP).
The absolute numbers of CD45+ total cells, γδT cells, and DP cells generated in each of
those cultures are also shown. A horizontal bar indicates the median value of individual B6
or NOD cultures. B. Plot showing the relative proportions of γδT cells in comparison to DP
(calculated as %γδT/(γδT + DP)) generated from single cell cultures of sorted DN2a, DN2b
and DN3a cells (left). To determine the commitment of the cells to αβ vs. γδ lineages, the
lineage choices of individual cells are shown as percentages of individual wells containing
γδT cells only, both γδT and DP cells, or DP cells only (right). p-values given below plots
were determined using Mann-Whitney U tests. Data are representative of two independent
experiments.
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FIGURE 4. B6 and NOD DN populations proliferate at similar rates in vitro, but NOD γδT cells
proliferate more rapidly than B6 γδT cells
DN cell populations were purified by cell sorting and stained with CFSE before co-culture
with OP9-DL1 cells. A. Total thymocytes (All) and purified DN1, DN2, DN3a, and DN3b
cells were harvested for analysis of remaining CFSE levels on days 1, 2, 3 and 4. B. Sorted
DN3a cells were cultured on OP9-DL1 cells, harvested after 4 days, and stained to
distinguish TCRγδ+ cells. Histograms show CFSE levels for B6 (solid gray) and NOD
(black line) cells. Data are representative of 3 independent experiments with similar results.
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FIGURE 5. Expression of TCR-Vγ rearrangements and other genes in sorted thymic NOD and
B6 γδT cells
QPCR results from TCRγδ+ cells sorted from NOD and B6 thymuses using primers to detect
subsets of specific TCR-Vβ rearrangements and other T cell genes. Data are shown as the
geometric mean +/− SD, n=2-5. For additional gene expression comparisons, see ref. 33.
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FIGURE 6. NOD thymocytes show evidence of a partial block at β-selection and abnormalities in
differentiation to DP cells in vivo
A. Histograms showing levels of activation-induced surface receptors CD27, CD28 and
CD5, on freshly isolated DN thymocytes from NOD (black lines) and B6 mice (solid gray),
using intracellular staining (ic) for TCRβ (top row) or TCRγδ (bottom row) to distinguish
cells that have passed through β-selection or γδ-selection respectively. Data are
representative of 3-4 independent experiments. B. Flow cytometric analysis showing CD44
vs. CD25 expression in DN subsets from freshly isolated NOD and B6 thymuses (left
panels). Percentages of cells in each quadrant are as indicated. A histogram comparing
CD25 surface expression levels between gated NOD and B6 CD44lo DN cells (DN3 and
DN4 cells) from two mice of each strain. Data are representative of >10 mice of each strain.
C. Flow cytometric analyses showing CD4 vs. CD8 plots for total thymocytes from NOD
and B6 mice (left), CD8 and CD4 gated cells, stained to distinguish immature (ISP) cells
from mature SP cells (middle panels), and histograms showing HSA levels for DN, DP,
CD8+ and CD4+ cells (right) which distinguish less mature cells (HSAhi) from more mature
cells (HSAlo). The red boxes indicate the intermediate HSA level for B6 CD8 ISP cells (top
panel, arrow) with no corresponding major population in the NOD thymus (bottom panel,
arrows). Data are representative of 3 independent experiments. D. Percentages of BrdU+
cells among DN2/3 (CD25+), DN4 (CD25−), and DP cell populations 1-3 days after in vivo
BrdU pulse-labeling, showing a major difference in accumulation of BrdU+ DP cells on day
2 between B6 and NOD mice. Mean + SD values over time are plotted for B6 and NOD
thymocytes.
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FIGURE 7. NOD cells exhibit differences in establishment of γδT vs. αβT cells in mixed bone
marrow chimeras
Bone marrow cells isolated from NOD and B6 mice and 1 × 106 cells from each strain were
mixed and injected into irradiated (NOD × B6)F1.Rag1−/− recipients. Mice were sacrificed
after 5-6 or 8-9 weeks and analyzed by flow cytometry for lymphocyte populations in
thymus and spleen using CD45.1 (NOD) and CD45.2 (B6) to distinguish donor strains. A.
Flow cytometric analysis of a representative chimeric mouse (#1) analyzed at 5 weeks post-
injection. Plots on the left show thymocytes were stained for CD4 and CD8 (upper panels)
and CD3ε and TCRγδ (lower panels). Splenocytes, shown on the right, were stained for
αβTCR and CD19, to distinguish B cells (upper panels), and CD3ε and TCRγδ (lower
panels). B, C. Summary of FACs staining results from six mixed bone marrow chimeric
mice, three analyzed after 5-6 weeks (#1-3) and three after 8-9 weeks (#4-6). B. Graphs
showing the ratio of TCRαβ+/TCRγδ+ cells in thymus (left) and spleen (right) generated
from B6 (black bars) and NOD (white bars) donors. C. Graph showing of the relative
percentages of B, αβT, and γδT lymphocytes derived from B6 and NOD donors in spleens
from the same individual chimeric mice.
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